Aide Pharmaceutical announced that Fu Hexiang, a concerted actor of the actual controller, pledged 4.5 million shares he holds, accounting for 34.14% of his holdings and 1.07% of the company's total share capital. As of the disclosure date, Fu Hexiang's cumulative pledged shares stood at 4.5 million. In the first quarter of 2026, Aide Pharmaceutical achieved revenue of 178 million yuan and net profit attributable to the parent of 7.61 million yuan.
Jiangsu Aidea Pharmaceutical Co LtdPledge of 4.5 million shares by concerted actor may signal financial strain or reduced control, negatively impacting investor sentiment.
